Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.15 Million SEK | 99.66% |
| 2022 | 2.08 Million SEK | 254.87% |
| 2021 | -1.34 Million SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 5.34 Million SEK | 29.32% |
| 2024 Q1 | 4.13 Million SEK | -0.6% |
| 2023 Q3 | 3.51 Million SEK | -17.86% |
| 2023 FY | 4.15 Million SEK | 99.66% |
| 2023 Q1 | 2.63 Million SEK | 26.36% |
| 2023 Q2 | 4.27 Million SEK | 62.5% |
| 2023 Q4 | 4.15 Million SEK | 18.39% |
| 2022 Q3 | 326 Thousand SEK | 122.16% |
| 2022 Q4 | 2.08 Million SEK | 538.96% |
| 2022 FY | 2.08 Million SEK | 254.87% |
| 2022 Q2 | -1.47 Million SEK | -20914.29% |
| 2022 Q1 | -7000.00 SEK | 99.48% |
| 2021 Q1 | - SEK | 0.0% |
| 2021 FY | -1.34 Million SEK | 0.0% |
| 2021 Q2 | -1.29 Million SEK | 0.0% |
| 2021 Q4 | -1.34 Million SEK | -76.74% |
| 2021 Q3 | -761 Thousand SEK | 41.19% |
| 2020 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | 39.187% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 96.568% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 96.568% |
| Arcoma AB | 28.02 Million SEK | 85.161% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 85.971% |
| BICO Group AB (publ) | 493.1 Million SEK | 99.157% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 93.335% |
| CellaVision AB (publ) | 126.03 Million SEK | 96.7% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | 31.987% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -134.85% |
| C-Rad AB (publ) | 64.09 Million SEK | 93.512% |
| Dignitana AB (publ) | 7.41 Million SEK | 43.896% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -12.405% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.935% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 347.064% |
| Iconovo AB (publ) | -4.86 Million SEK | 185.541% |
| Integrum AB (publ) | 22.36 Million SEK | 81.401% |
| Luxbright AB (publ) | 8000.00 SEK | -51887.5% |
| Mentice AB (publ) | 14.1 Million SEK | 70.512% |
| OssDsign AB (publ) | 4.3 Million SEK | 3.369% |
| Paxman AB (publ) | 19.99 Million SEK | 79.204% |
| Promimic AB (publ) | 330 Thousand SEK | -1160.303% |
| Qlife Holding AB (publ) | 7.29 Million SEK | 42.965% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 65.106% |
| ScandiDos AB (publ) | 22.69 Million SEK | 81.67% |
| Sectra AB (publ) | 36.59 Million SEK | 88.634% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 90.322% |
| Senzime AB (publ) | 20.34 Million SEK | 79.553% |
| SpectraCure AB (publ) | 1.00 SEK | -415899900.0% |
| Stille AB | 66.55 Million SEK | 93.751% |
| Vitrolife AB (publ) | 413 Million SEK | 98.993% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 97.063% |